Enoxaparin Sodium Injection, Solution
Product Images NDC 70710-1762

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 70710-1762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 01)

An instructional line drawing showing two gloved hands pulling apart a syringe and needle assembly, indicated by bidirectional arrows between them. This diagram illustrates the disconnection or separation step of assembling or handling a syringe for injection.*

FDA Label Image

Figure B (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 02)

An instructional illustration showing a hand administering an injection into the forearm. The syringe is shown with an arrow indicating the direction of injection, depicting proper technique for subcutaneous or intravenous injection.*

FDA Label Image

Figure C (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 03)

An illustration showing a hand holding a syringe with the needle inserted into the skin, with an arrow pointing right to indicate the direction of injection, depicting the subcutaneous administration technique.*

FDA Label Image

Figure D (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 04)

An instructional line drawing showing a hand holding a syringe, with an arrow indicating the removal of the syringe cap. The image demonstrates how to prepare the syringe for use, likely related to Enoxaparin Sodium injection administration.*

FDA Label Image

Figure E (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 05)

An instructional illustration showing a gloved hand disposing of a used syringe into a small biohazard sharps container labeled with the biohazard symbol. The image demonstrates proper disposal of injection equipment, relevant to the administration of Enoxaparin Sodium injection.*

FDA Label Image

Structural Formula (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 06)

Chemical structure of enoxaparin sodium showing repeating units with substituents R1 and R2 as defined in the diagram.*

FDA Label Image

Structural Formula 2 (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 07)

Chemical structure diagram depicting part of the enoxaparin sodium molecule, including sugar ring moieties with attached chemical groups like COONa and NHSO3Na, and variables X, R, and n indicating structural variations.*

FDA Label Image

Figure 1 (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 08)

A forest plot chart comparing the relative risk between Enoxaparin and unfractionated heparin (UFH) across various patient subgroups, including sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent use, time to treatment, and PCI status. The chart shows relative risk points with confidence intervals and percentage reductions in risk for both treatments.*

FDA Label Image

Figure 2 (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 09)

A Kaplan-Meier type plot showing hazard distribution function over time to death or myocardial re-infarction (days) comparing Enoxaparin and UFH treatments. The graph includes a main plot up to 30 days and an inset showing data at 1 year, with statistical significance indicated by log-rank test p-values. Below the x-axis, the number of patients at risk for each treatment group is displayed at various time points.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 10)

Enoxaparin Sodium Injection USP 30 mg/0.3 mL single-dose syringes with automatic safety device for subcutaneous injection. The package label shows the product name, strength, dosage form, and includes manufacturer and distributor names: Italianbanco S.p.A. and Zydus Pharmaceuticals USA Inc. The label also displays usage instructions and warnings on storage and administration.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 11)

Packaging label for Enoxaparin Sodium Injection USP 40 mg/0.4 mL by Zydus Pharmaceuticals USA Inc. The carton contains single-dose syringes with an automatic safety device for subcutaneous injection. The label includes storage instructions, usage warnings, and directions illustrated for safe injection use.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 12)

Packaging label for Enoxaparin Sodium Injection USP, 60 mg/0.6 mL solution for injection. The label indicates single-dose syringes with an automatic safety device for subcutaneous injection. The product is supplied by Zydus Pharmaceuticals USA Inc, with the NDC 70710-1759-6. The carton includes directions for use with illustrations and safety notes, suitable for intravascular and subcutaneous routes.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 13)

Label and carton graphics for Enoxaparin Sodium Injection USP 80 mg/0.8 mL single-dose syringes. The product is marketed by Zydus Pharmaceuticals USA Inc. The labeling notes the injection is for subcutaneous use with an automatic safety device and includes directions illustrated for use. The label states the product is prescription only.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 14)

Packaging label for Enoxaparin Sodium Injection USP 100 mg/mL, a single-dose syringe solution with automatic safety device for subcutaneous injection. The label includes dosage information, directions for use with illustrations, storage instructions, manufacturer Zydus Pharmaceuticals USA Inc., and NDC 70710-1761-6. The package contains ten 1 mL syringes intended for prescription use.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 15)

Packaging label for Enoxaparin Sodium Injection USP 120 mg/0.8 mL by Zydus Pharmaceuticals USA Inc. The label indicates the product is a single-dose syringe with an automatic safety device for subcutaneous injection. The package contains ten 0.8 mL syringes and includes usage directions and storage information.*

FDA Label Image

Image (Bdf0248f 2aff 42cd 8bf4 639c0ae2d913 16)

Packaging label for Enoxaparin Sodium Injection USP 150 mg/mL in single-dose 1 mL syringes. The label states it is for subcutaneous injection and includes an automatic safety device. The product is distributed by Zydus Pharmaceuticals USA Inc. and includes usage directions and handling warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.